• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Biotech

direction arrow
Favicon Fierce Biotech

Anaptys plans to split into 2 businesses

AnaptysBio plans to split into two publicly traded companies.
James Waldron Sep 30, 2025 9:35am
A close-up view of a jigsaw puzzle with a missing piece
Favicon Fierce Biotech

Novo Holdings-backed biotech raises $205M to fill gout care gap

Sep 30, 2025 8:00am
Enhertu

AZ, Daiichi's Enhertu notches another win in early breast cancer

Sep 29, 2025 12:00pm
Moderna

Moderna says updated mNEXSPIKE induces strong immune response

Sep 23, 2025 10:15am
SK Bioscience

SK eyes Xcopri expansion with phase 3 win in new seizure type

Sep 17, 2025 11:32am
scales of justice court legal law
Favicon Fierce Biotech

FibroGen pays SEC $1.2M over claims of 'reverse engineered' data

Sep 11, 2025 10:41am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings